Significant Ownership of Citius Pharmaceuticals, Inc.

Signature - Title
/s/ Leonard Mazur - Leonard Mazur, Chief Executive Officer
Location
Cranford, NJ
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Citius Pharmaceuticals, Inc..

Notify me when Citius Pharmaceuticals, Inc. files a new Schedule 13D/G report.

⭐ Subscribe ⭐

Significant Ownership of Citius Pharmaceuticals, Inc.

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
CTOR Citius Oncology, Inc. Common Shares, $0.0001 par value per share 78% $79,920,034 66,049,615 0% Citius Pharmaceuticals, Inc. 10 Dec 2025

Schedules 13D/G Reported by Citius Pharmaceuticals, Inc.:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Filing Date
* An asterisk sign (*) next to the price indicates that the price is likely invalid.